Identification |
Name: | (2S,8E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-[(propoxyamino)methylidene]-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate |
Synonyms: | 3-Formylrifamycin SV O-propyloxime;NSC 143472;BRN 5418207;2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 3-formyl-5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, O-propyloxime;38128-91-5;NSC143472;Rifamycin, 3-((propoxyimino)methyl)-;NCI 143-472;AF/08;LS-64208;Rifamycin, 3-((propoxyimino)methyl)- (9CI);3-Formylrifamycin SV O-propyloxime; Rifamycin, {3-[(propoxyimino)methyl]-};50957-55-6;84309-01-3 |
CAS: | 38128-91-5;50957-55-6;84309-01-3 |
Molecular Formula: | C41H54N2O13 |
Molecular Weight: | 782.8731 |
InChI: | InChI=1/C41H54N2O13/c1-11-16-54-42-18-26-31-36(49)29-28(35(26)48)30-38(24(7)34(29)47)56-41(9,39(30)50)53-17-15-27(52-10)21(4)37(55-25(8)44)23(6)33(46)22(5)32(45)19(2)13-12-14-20(3)40(51)43-31/h12-15,17-19,21-23,27,32-33,37,42,45-47,49H,11,16H2,1-10H3,(H,43,51)/b13-12+,17-15+,20-14+,26-18+/t19-,21+,22+,23+,27-,32-,33-,37+,41-/m0/s1 |
Molecular Structure: |
|
Properties |
Density: | 1.32g/cm3 |
Refractive index: | 1.606 |
Safety Data |
|
|